3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Neoplasms
10
Venous Thromboembolism
7
Venous Thrombosis
3
Treatment of Venous Thromboembolism in Cancer Patients
3
Pulmonary Embolism
3
Upper Extremity Deep Vein Thrombosis
2
Thrombosis
1
Recurrence
1
Prevention of Venous Thromboembolism
1
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
1
Myeloproliferative Disorders
1
Lung Neoplasms
1
Hemorrhage
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
apixaban
3
Warfarin
2
Dalteparin
2
Aspirin
2
salicylhydroxamic acid
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
edoxaban
1
Simvastatin
1
Rivaroxaban
1
Radiotherapy, Conformal
1
Paclitaxel
1
Observation
1
Injections
1
Fondaparinux
1
Enoxaparin
1
Docetaxel
1
Data Collection
1
Dabigatran
1
Clopidogrel
1
Arginine Vasopressin
1
Arginine
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thrombosis
×
Rivaroxaban
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts